Tag: investor

GREENWICH, Conn., June 13, 2025 (GLOBE NEWSWIRE) -- Leverage Shares by Themes, an issuer of innovative exchange-traded products, is excited to announce the launch of the Leverage Shares 2X long BA Daily ETF (ticker: BOEG), a new single stock leveraged ETF, available for trading starting June 13, 2025 on Nasdaq. The product is designed to equip investors to amplify returns (up and down) and dynamically participate in the performance of a leading transportation and aerospace company. The new ETF is tailored to target a 200% exposure to the daily performance of its underlying stock, Boeing Co. (BA), offering sophisticated traders and the retail investor an efficient tool to capitalize on market movements at an industry low management fee for single stock leveraged ETFs at .75%.

SINGAPORE, June 13, 2025 (GLOBE NEWSWIRE) -- Multi Ways Holdings Limited (“Multi Ways,” the “Company” or the “Issuer”) (NYSE American: MWG), a leading supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region, announced that it has filed its annual report on Form 20-F, including its financial results, for the fiscal year ended December 31, 2024 (the “2024 Annual Report”) with the U.S. Securities and Exchange Commission. The 2024 Annual Report can be accessed under the “Investor Relations” section of the Company’s investor relations website at www.multiwaysholdings.com.

MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard^® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical Device Regulation (MDR) for the CGuard^® Prime EPS.

URUMQI, China, June 13, 2025 (GLOBE NEWSWIRE) -- Chanson International Holding (Nasdaq: CHSN) (the “Company” or “Chanson”), a provider of bakery, seasonal, and beverage products through its chain stores in China and the United States, today announced that it has priced a best-efforts public offering with gross proceeds to the Company expected to be approximately $8 million, before deducting placement agent fees and other estimated expenses payable by the Company, excluding the exercise of any warrant offered.

SAN FRANCISCO, CALIFORNIA, June 13, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE^® natural killer (NK) cell engager platform, today announced the appointment of David C. Mun-Gavin to its Board of Directors.

– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma –

Millicom (Tigo) Announces Partial Closing of Infrastructure Deal with SBA and Intention to Declare a Special Dividend of $2.50 per Share Representing Around 45% of the Proceeds

Viasat expects to receive $568 million from Ligado in fiscal year 2026

TOKYO, June 13, 2025 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE” or “the Company”), a Japanese real estate developer of luxury residential properties including single-family homes and condominiums across Tokyo and Kanagawa prefectures and Sapporo, is announcing the signing of a sales contract for its planned hotel, ENT TERRACE Tsukiji 6 Chome.

SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 26,000 shares of the Company’s stock (the “Inducement Grant”) to newly hired employees on June 10, 2025 (the “Grant Date”), in connection with the commencement of employment.